Medpace · 3 days ago
Director - Study Start-Up Project Management (Incentives Available)
Medpace is a full-service clinical contract research organization (CRO) seeking a Director of Study Start-Up to support their growing Study Start-Up/Regulatory Submissions team. This role involves overseeing activities and timelines related to study start-up and regulatory submissions, contributing to the growth of the team, and maintaining client relationships.
BiotechnologyPharmaceutical
Responsibilities
Contribute directly to the growth and strategic development of a large, global Study Start-Up team
Develop and identify continuous improvement opportunities of internal processes
Oversee Study Start-Up/Regulatory Submissions activities and timelines to ensure they are in accordance with Medpace standard operating procedures and study protocols
Provide input on new business development opportunities; and
Develop and maintain relationships with clients
Qualification
Required
Bachelor's degree in Life Sciences or related field
8+ years as a study start-up senior leader within a CRO
Excellent presentation, negotiation, documentation, leadership, team-orientation, and interpersonal skills
Strong customer focus with ability to manage challenging priorities and remain flexible and adaptive in stressful situations
Excellent written and oral communication
Experience managing and developing a team
Preferred
Advanced degree is preferred
Benefits
Competitive bonus program
Sign-on/relocation bonus
Equity awards
Flexible work environment
Competitive PTO packages, starting at 20+ days
Competitive compensation and benefits package
Company-sponsored employee appreciation events
Employee health and wellness initiatives
Community involvement with local nonprofit organizations
Discounts on local sports games, fitness gyms and attractions
Modern, ecofriendly campus with an on-site fitness center
Structured career paths with opportunities for professional growth
Discounted tuition for UC online programs
Company
Medpace
Medpace, Inc., a clinical research organization, provides clinical development services for pharmaceutical and biotechnology
Funding
Current Stage
Public CompanyTotal Funding
unknown2016-08-10IPO
2014-02-24Acquired
Recent News
MarketScreener
2025-11-19
2025-10-27
2025-10-25
Company data provided by crunchbase